Bristol Myers has reported a death in its clinical trials of an experimental cell therapy for autoimmune diseases, potentially adding to safety concerns about a promising new class of treatments. https://t.co/U6L1bkETOX
"I was warned about this by people opposing the [MAID] law that told me, 'We see your motivation is good, but you will see, once you open the door you will not close it and it will open wider.' And this is what happened," former Que Premier Couillard https://t.co/hoWy1ctfdo
𝐖𝐨𝐫𝐥𝐝 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐒𝐚𝐟𝐞𝐭𝐲 𝐃𝐚𝐲 𝟐𝟎𝟐𝟔 | 𝐖𝐇𝐎 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐖𝐞𝐛𝐢𝐧𝐚𝐫
On 𝟏𝟕 𝐒𝐞𝐩𝐭𝐞𝐦𝐛𝐞𝐫 𝟐𝟎𝟐𝟔, the 𝐖𝐨𝐫𝐥𝐝 𝐏𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐀𝐥𝐥𝐢𝐚𝐧𝐜𝐞 will join the 𝐖𝐇𝐎 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐰𝐞𝐛𝐢𝐧𝐚𝐫 𝐨𝐧 𝐒𝐚𝐟𝐞 𝐂𝐚𝐫𝐞 𝐟𝐨𝐫 𝐍𝐨𝐧𝐜𝐨𝐦𝐦𝐮𝐧𝐢𝐜𝐚𝐛𝐥𝐞 𝐃𝐢𝐬𝐞𝐚𝐬𝐞𝐬, 𝐦𝐚𝐫𝐤𝐢𝐧𝐠 𝐖𝐨𝐫𝐥𝐝 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐒𝐚𝐟𝐞𝐭𝐲 𝐃𝐚𝐲 𝟐𝟎𝟐𝟔.
Jolanta Bilinska, Founding Director and Treasurer of the World Patients Alliance, will bring the patient perspective to the discussion, speaking on:
“𝐿𝑖𝑣𝑖𝑛𝑔 𝑤𝑖𝑡ℎ 𝑁𝐶𝐷𝑠 𝑎𝑛𝑑 𝑁𝑎𝑣𝑖𝑔𝑎𝑡𝑖𝑛𝑔 𝑆𝑎𝑓𝑒𝑡𝑦 𝑅𝑖𝑠𝑘𝑠 𝐴𝑐𝑟𝑜𝑠𝑠 𝑡ℎ𝑒 𝐶𝑜𝑛𝑡𝑖𝑛𝑢𝑢𝑚 𝑜𝑓 𝐶𝑎𝑟𝑒.”
Her contribution will highlight why patient safety must remain central throughout the NCD care journey, from prevention and early detection to diagnosis, treatment, follow-up and long-term care.
The webinar will bring together experts and patient representatives to explore patient safety risks linked to NCDs and multimorbidity, approaches to safer and higher-quality care, and the importance of patient perspectives in strengthening health systems.
𝟏𝟕 𝐒𝐞𝐩𝐭𝐞𝐦𝐛𝐞𝐫 𝟐𝟎𝟐𝟔
11:00–12:30 EEST | 10:00–11:30 CEST | 13:00–14:30 Pakistan Time (UTC+5)
𝐋𝐚𝐧𝐠𝐮𝐚𝐠𝐞: 𝐄𝐧𝐠𝐥𝐢𝐬𝐡, 𝐰𝐢𝐭𝐡 𝐬𝐢𝐦𝐮𝐥𝐭𝐚𝐧𝐞𝐨𝐮𝐬 𝐢𝐧𝐭𝐞𝐫𝐩𝐫𝐞𝐭𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐑𝐮𝐬𝐬𝐢𝐚𝐧
𝑹𝒆𝒈𝒊𝒔𝒕𝒆𝒓 𝒉𝒆𝒓𝒆: https://t.co/pkAVYCUzU4
Join the conversation and help advance safe care for noncommunicable diseases and safe care for life.
#WorldPatientSafetyDay #WPSD2026 #PatientSafety #NCDs #SafeCareForLife #PatientVoice #WorldPatientsAlliance #WHOEurope
@WHO@WHOAFRO@WHOWPRO@WHOEMRO@WHONigeria@UN@UNICEF@PapievaIrina@kchalkidou@DrKatiadePinho@Shams_Syed@emmajdoble@GloriaEkeng@hhask@AndrewRSpiegel
Another Heart Drug Fails, Shocking Cardiologists.
Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease. https://t.co/koIEatbLvA